BioConsortia's most recent funding was $15 million
BioConsortia Inc. has raised $15 million to conduct hundreds of field trials using its biotechnology this year with third-party partners.
BioConsortia, Inc., has raised $15 millions to conduct hundreds field trials this year using its biotechnology with third-party partner in fields in North America. Asia, Latin America, and Europe.
The Davis-based firm announced that it would begin the trials earlier this month but did not disclose how much it raised.